Fludarabine, cyclophosphamide, and rituximab treatment achieves long-Term disease-free survival in IGHV-mutated chronic lymphocytic leukemia

Philip A. Thompson, Constantine S. Tam, Susan M. O'Brien, William G. Wierda, Francesco Stingo, William Plunkett, Susan C. Smith, Hagop M. Kantarjian, Emil J. Freireich, Michael J. Keating

Research output: Contribution to journal › Article › peer-review

426 Scopus citations

Fingerprint

Dive into the research topics of 'Fludarabine, cyclophosphamide, and rituximab treatment achieves long-Term disease-free survival in IGHV-mutated chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry